


Kent-Athlone Pharma Group Revenue
Pharmaceutical Manufacturing • • 21-50 Employees
Kent-Athlone Pharma Group revenue & valuation
| Annual revenue | $2,652,205 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $8,500,000 |
| Total funding | No funding |
Key Contacts at Kent-Athlone Pharma Group
Terry Petersen
Chief Executive Officer
Michael Flock
Director Business Transformation
Ernest Owusu
Group Human Resources Director
Derek Martin
Director Of Technical Operations
David Wright
Director
David Wright
Director
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 3254 |
| Employees | 21-50 |
| Socials |
Kent-Athlone Pharma Group Email Formats
Kent-Athlone Pharma Group uses 1 email format. The most common is {first name}.{last name} (e.g., john.doe@kent-athlone.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@kent-athlone.com | 100% |
About Kent-Athlone Pharma Group
The Kent-Athlone Pharma Group, represents the coming together of three pharmaceutical companies across the UK and Ireland. Kent Pharma UK Ltd founded in 1986 and originally known as Kent Pharmaceuticals, with our UK headquarters in Ashford, Kent, Athlone Laboratories, founded in 1974 based in Co. Roscommon, Ireland and Athlone Pharmaceuticals, founded in 2020 with our EU headquarters in Dublin. With our shared vision and combined experience within the pharmaceutical industry, we have access to both the UK and EU markets. As a group, our strategic focus is on developing, in-licensing, acquiring and commercialising value-added medicines.
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Kent-Athlone Pharma Group has 15 employees across 7 departments.
Departments
Number of employees
Funding Data
Kent-Athlone Pharma Group has never raised funding before.
Frequently asked questions
4.8
40,000 users



